(Reuters) - Alere Inc said it initiated a voluntary recall of certain blood clot test strips in the United States following reports of nine serious adverse events that included bleeding related to the ...
Alere Inc. has announced that its Alere™ Reader has received 510(k) marketing clearance from the U.S. Food and Drug Administration. The Alere Reader was released in Europe and select Asian markets in ...
* Alere I testing applications have previously been clia-waived for Influenza a & b and strep a Source text for Eikon: Further company coverage: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback